Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS ...

Imagine you're about to give a presentation to a room full of people.

Beta blockers—drugs commonly prescribed for a range of cardiac conditions, including heart attacks—provide no clinical benefit for patients who have had an uncomplicated myocardial infarction with ...

Beta-blockers are excellent drugs. They're cheap and effective; feature prominently in hypertension guidelines; and remain a sine qua non for coronary artery disease, myocardial infarction, and heart ...

Individuals who are simultaneously taking certain antidepressants and beta blockers had a decrease in systolic blood pressure (BP) and an increase in their risk for bradycardia, according to new data ...